Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_3cbb5e89-9d50-4677-a2ea-99b7b6cff536.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: POLEWACZYK JAMES F (CORPORATE VICE PRESIDENT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 194 Acquired 4833 Direct
2012-02-14 Common Stock M 282 Acquired 5115 Direct
2012-02-14 Common Stock M 400 Acquired 5515 Direct
2012-02-14 Common Stock M 257 Acquired 5772 Direct
2012-02-14 Common Stock M 714 Acquired 6486 Direct
2012-02-14 Common Stock F 615 $87.42 Disposed 5871 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 8105 Acquired 2019-02-13 Common Stock (8105) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 929 Acquired Common Stock (929) Direct
2012-02-14 Restricted Stock Unit $ M 194 Disposed Common Stock (194) Direct
2012-02-14 Restricted Stock Unit $ M 282 Disposed Common Stock (282) Direct
2012-02-14 Restricted Stock Unit $ M 400 Disposed Common Stock (400) Direct
2012-02-14 Restricted Stock Unit $ M 257 Disposed Common Stock (257) Direct
2012-02-14 Restricted Stock Unit $ M 714 Disposed Common Stock (714) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 1,850 shares on 02/14/2013, 02/14/2014 and 02/14/2015, 1849 shares on 02/14/2016, and the remaining 706 shares on 02/14/2017.

F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.